HK Stock MarketDetailed Quotes

01099 SINOPHARM

Watchlist
  • 21.550
  • -0.200-0.92%
Market Closed Apr 26 16:08 CST
67.25BMarket Cap6.73P/E (TTM)

SINOPHARM Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

SINOPHARM Earnings Date

Currency: CNY

Period

FY2023 Annual Report

Mar 22, 2024

Revenue(YoY)

596.57B

+8.05%
EPS(YoY)

2.91

+7.74%
Analyst Rating

Strong Buy

Apr 27, 2024

SINOPHARM Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Mar 22, 20242023/Q4150.650B / 150.446B--
Oct 27, 20232023/Q3144.969B / 152.155B--
Aug 25, 20232023/Q2155.433B / 144.735B--
Apr 27, 20232023/Q118.687B / ----
DatePeriodRevenue/EstimateEarnings Call
Mar 22, 20242023/Q4150.650B / 150.446B--
Oct 27, 20232023/Q3144.969B / 152.155B--
Aug 25, 20232023/Q2155.433B / 144.735B--
Apr 27, 20232023/Q118.687B / ----

SINOPHARM Earnings Reports

  • SINOPHARM: Annual Report 2023

    Apr 26 04:30 ET

  • SINOPHARM: ANNOUNCEMENT PRINCIPAL UNAUDITED ACCOUNTING DATA AND FINANCIAL INDICATORS OF SINOPHARM (CNCM LTD) FOR THE FIRST QUARTER ENDED 31 MARCH 2024

    Apr 25 09:17 ET

  • SINOPHARM: ANNOUNCEMENT PRINCIPAL UNAUDITED ACCOUNTING DATA AND FINANCIAL INDICATORS OF SINOPHARM ACCORD FOR THE FIRST QUARTER ENDED 31 MARCH 2024

    Apr 25 06:00 ET

  • SINOPHARM: NOTICE OF BOARD MEETING

    Apr 15 18:08 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Apr 27, 2024

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    HK
    Overall
    Symbol
    Latest Price
    %Chg